4.8 Article

Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi

期刊

NATURE
卷 501, 期 7465, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nature12423

关键词

-

资金

  1. Telethon [GSP08002, GGP06166]
  2. Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 8623]
  3. EU (FP7 Lipidomicnet)
  4. AIRC [MFAG 10585]
  5. Academy of Finland
  6. Sigrid Juselius Foundation
  7. Study Abroad Scholarship from the Taiwan Ministry of Education
  8. Grants-in-Aid for Scientific Research [25113517, 23591347, 24659084, 24390046] Funding Source: KAKEN
  9. British Heart Foundation [PG/11/109/29247] Funding Source: researchfish
  10. Medical Research Council [MC_U105184308] Funding Source: researchfish
  11. MRC [MC_U105184308] Funding Source: UKRI

向作者/读者索取更多资源

Newly synthesized proteins and lipids are transported across the Golgi complex via different mechanisms whose respective roles are not completely clear. We previously identified a non-vesicular intra-Golgi transport pathway for glucosylceramide (GlcCer)-the common precursor of the different series of glycosphingolipids-that is operated by the cytosolic GlcCer-transfer protein FAPP2 (also known as PLEKHA8) (ref. 1). However, the molecular determinants of the FAPP2-mediated transfer of GlcCer from the cis-Golgi to the trans-Golgi network, as well as the physiological relevance of maintaining two parallel transport pathways of GlcCer-vesicular and non-vesicular-through the Golgi, remain poorly defined. Here, using mouse and cell models, we clarify the molecular mechanisms underlying the intra-Golgi vectorial transfer of GlcCer by FAPP2 and show that GlcCer is channelled by vesicular and non-vesicular transport to two topologically distinct glycosylation tracks in the Golgi cisternae and the trans-Golgi network, respectively. Our results indicate that the transport modality across the Golgi complex is a key determinant for the glycosylation pattern of a cargo and establish a new paradigm for the branching of the glycosphingolipid synthetic pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cell Biology

Molecular mechanisms of PI4K regulation and their involvement in viral replication

Jacob A. McPhail, John E. Burke

Summary: Lipid phosphoinositides play important roles as signaling molecules and markers of organelle identity in eukaryotic cells. Viruses can manipulate the kinases and phosphatases involved in phosphoinositide generation for their replication. This review focuses on PI4KA and PI4KB, discussing their roles in signaling, membrane trafficking, and virus manipulation. The molecular mechanisms by which PI4KA and PI4KB are activated and usurped by viruses are also explored.

TRAFFIC (2023)

Review Cell Biology

The lipotype hypothesis

Giovanni D'Angelo, Gioele La Manno

Summary: The concept of lipotypes suggests that lipid composition plays a crucial role in regulating cell fate. Recent evidence indicates that lipid composition modulates cell response to signaling cues. The variability in cell lipid composition assists the divergence of differentiation trajectories, leading to the establishment of multiple cell identities.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)

Article Immunology

Distinct changes in endosomal composition promote NLRP3 inflammasome activation

Zhirong Zhang, Rossella Venditti, Li Ran, Zengzhen Liu, Karl Vivot, Annette Schurmann, Juan S. Bonifacino, Maria Antonietta De Matteis, Romeo Ricci

Summary: The NLRP3 inflammasome plays a crucial role in the innate immune response, and disruption of the endoplasmic reticulum-endosome membrane contact sites (EECS) leads to NLRP3 accumulation in endosomes and activation of the inflammasome. Lowering endosomal phosphatidylinositol 4-phosphate (PI4P) levels prevents NLRP3 association with endosomes and inhibits inflammasome activation. This discovery helps us better understand the activation mechanism of the inflammasome.

NATURE IMMUNOLOGY (2023)

Review Biotechnology & Applied Microbiology

Beyond PI3Ks: targeting phosphoinositide kinases in disease

John E. Burke, Joanna Triscott, Brooke M. Emerling, Gerald R. Hammond

Summary: This Review describes the structure, function, regulation, and disease roles of clinically relevant PIKs outside of class I PI3Ks, as well as the development of potent and specific small-molecule inhibitors. Phosphoinositide kinases are master regulators of cellular processes and their dysregulation has been implicated in various human diseases. Recent years have seen increased interest in targeting phosphoinositide kinases beyond class I PI3Ks, leading to the clinical development of selective inhibitors. This comprehensive analysis provides an overview of the current understanding and progress in the development of phosphoinositide kinase inhibitors.

NATURE REVIEWS DRUG DISCOVERY (2023)

Article Multidisciplinary Sciences

PKD autoinhibition in trans regulates activation loop autophosphorylation in cis

Ronja Reinhardt, Kai Hirzel, Gisela Link, Stephan A. Eisler, Tanja Hagele, Matthew A. H. Parson, John E. Burke, Angelika Hausser, Thomas A. Leonard

Summary: Phosphorylation is a common mechanism in cell signaling, and protein kinases are often regulated by phosphorylation. However, PKD regulates itself through dimerization-mediated trans-autoinhibition, followed by autophosphorylation, to control its activity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Multidisciplinary Sciences

Oncogenic mutations of PIK3CA lead to increased membrane recruitment driven by reorientation of the ABD, p85 and C-terminus

Meredith L. Jenkins, Harish Ranga-Prasad, Matthew A. H. Parson, Noah J. Harris, Manoj K. Rathinaswamy, John E. Burke

Summary: The PIK3CA gene is frequently mutated in human cancer, and this study reveals the molecular mechanisms underlying the increased activity mediated by different oncogenic mutations in PIK3CA. Through a combination of biochemical assays and HDX-MS, the authors uncover unique regulatory mechanisms and explain how these mutations activate PI3K. This work has important implications for the development of mutant selective inhibitors.

NATURE COMMUNICATIONS (2023)

Article Chemistry, Inorganic & Nuclear

Metal-Complexes Bearing Releasable CO Differently Modulate Amyloid Aggregation

Sara La Manna, Valentina Roviello, Fabiana Napolitano, Anna Maria Malfitano, Vittoria Monaco, Antonello Merlino, Maria Monti, Konrad Kowalski, Lukasz Szczupak, Daniela Marasco

Summary: Three photoactivable metal-CORMs have been found to modulate the self-aggregation mechanism of the peptide covering the second helix of the C-terminal domain of nucleophosmin 1 in different ways, with two acting as aggregating agents and one as an anti-aggregating agent. This highlights the importance of ligand systems in the development of metal-based drugs with potential application as antiamyloidogenic agents.

INORGANIC CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Enzyme Replacement Therapy for FABRY Disease: Possible Strategies to Improve Its Efficacy

Ilaria Iacobucci, Bruno Hay Mele, Flora Cozzolino, Vittoria Monaco, Chiara Cimmaruta, Maria Monti, Giuseppina Andreotti, Maria Monticelli

Summary: Enzyme replacement therapy is the only option for Fabry patients with no AGAL activity, but it has limitations. This study explores two possible approaches to optimize the therapy: combining it with pharmacological chaperones and targeting AGAL interactors. The findings demonstrate that galactose can prolong AGAL half-life and provide a list of potential drugs that can affect enzyme replacement therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids

Anyelo Duran, David A. Priestman, Macarena Las Heras, Boris Rebolledo-Jaramillo, Valeria Olguin, Juan F. Calderon, Silvana Zanlungo, Jaime Gutierrez, Frances M. Platt, Andres D. Klein

Summary: Using a systems genetics approach, we identified 30 shared predicted modifier genes between hepatic lysosomal enzymes and glycosphingolipids (GSLs), clustered in three pathways and associated with other diseases. Surprisingly, these genes are regulated by ten common transcription factors and miRNA-340p. These findings suggest novel therapeutic targets for Lysosomal Storage Disorders (LSDs) and indicate the potential involvement of GSL metabolism in other pathologies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Glycolipid transfer protein knockout disrupts vesicle trafficking to the plasma membrane

Henrik Nurmi, Anders P. E. Backman, Josefin Halin, Max Lonnfors, Tomas Blom, Pia Roos-Mattjus, Peter Mattjus

Summary: The glycolipid transfer protein (GLTP) is involved in various cellular processes, including lipid transport, sensing and regulating glycosphingolipid homeostasis, and facilitating vesicular transport. Knocking out GLTP in HeLa cells affected motility, three-dimensional growth, and cellular metabolism. The interaction between GLTP and VAP-A is important for cell adhesion, cohesion, and three-dimensional growth, and GLTP expression directly impacts vesicular trafficking.

JOURNAL OF BIOLOGICAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

ATP-competitive and allosteric inhibitors induce differential conformational changes at the autoinhibitory interface of Akt1

Alexandria L. Shaw, Matthew A. H. Parson, Linda Truebestein, Meredith L. Jenkins, Thomas A. Leonard, John E. Burke

Summary: Akt is a key regulator of cell growth signaling and its hyperactivation is oncogenic. This study used hydrogen deuterium exchange mass spectrometry to investigate the conformational changes induced by Akt inhibitors. The findings provide valuable insights for designing targeted therapeutics against Akt.

STRUCTURE (2023)

Article Cell Biology

Molecular basis for differential activation of p101 and p84 complexes of PI3Ky by Ras and GPCRs

Manoj K. Rathinaswamy, Meredith L. Jenkins, Benjamin R. Duewell, Xuxiao Zhang, Noah J. Harris, John T. Evans, Jordan T. B. Stariha, Udit Dalwadi, Kaelin D. Fleming, Harish Ranga-Prasad, Calvin K. Yip, Roger L. Williams, Scott D. Hansen, John E. Burke

Summary: This study investigates the activation mechanisms of phosphoinositide 3-kinase (PI3Ky) in immune cells. Using various experimental methods, the researchers identified molecular differences between the p110y-p84 and p110y-p101 complexes, which explain their differential membrane recruitment and activation by Ras and GPCRs. The findings provide key insights into the molecular basis of PI3Ky complex activation.

CELL REPORTS (2023)

Article Cell Biology

Engineered Synthetic STxB for Enhanced Cytosolic Delivery

Justine Hadjerci, Anne Billet, Pascal Kessler, Gilles Mourier, Marine Ghazarian, Anthony Gonzalez, Christian Wunder, Nesrine Mabrouk, Eric Tartour, Denis Servent, Ludger Johannes

Summary: Many molecular targets for cancer therapy are located in the cytosol, but therapeutic macromolecules generally cannot spontaneously translocate across membranes to reach these targets. To enhance cytosolic delivery, researchers have used Shiga toxin B-subunit (STxB) to deliver therapeutic principles to disease-relevant cells expressing its receptor, Gb3. By introducing unnatural amino acids and functionalizing them with hydrophobic entities, the membrane translocation of STxB was increased by a factor of 2.5, opening up new biomedical opportunities.
Editorial Material Cell Biology

Dynamic tandem proximity-based proteomics-Protein trafficking at the proteome-scale

Eric Chevet, Maria Antonietta De Matteis, Eeva-Liisa Eskelinen, Hesso Farhan

TRAFFIC (2023)

Article Medicine, Research & Experimental

CERT1 mutations perturb human development by disrupting sphingolipid homeostasis

Charlotte Gehin, Museer A. Lone, Winston Lee, Laura Capolupo, Sylvia Ho, Adekemi M. Adeyemi, Erica H. Gerkes, Alexander P. A. Stegmann, Estrella Lopez-Martin, Eva Bermejo-Sanchez, Beatriz Martinez-Delgado, Christiane Zweier, Cornelia Kraus, Bernt Popp, Vincent Strehlow, Daniel Graefe, Ina Knerr, Eppie R. Jones, Stefano Zamuner, Luciano A. Abriata, Vidya Kunnathully, Brandon E. Moeller, Anthony Vocat, Samuel Rommelaere, Jean-Philippe Bocquete, Evelyne Ruchti, Greta Limoni, Marine Van Campenhoudt, Samuel Bourgeat, Petra Henklein, Christian Gilissen, Bregje W. van Bon, Rolph Pfundt, Marjolein H. Willemsen, Jolanda H. Schieving, Emanuela Leonardi, Fiorenza Soli, Alessandra Murgia, Hui Guo, Qiumeng Zhang, Kun Xia, Christina R. Fagerberg, Christoph P. Beier, Martin J. Larsen, Irene Valenzuela, Paula Fernandez-alvarez, Shiyi Xiong, Robert Smigiel, Vanesa Lopez-Gonzalez, Lluis Armengol, Manuela Morleo, Angelo Selicorni, Annalaura Torella, Moira Blyth, Nicola S. Cooper, Valerie Wilson, Renske Oegema, Yvan Herenger, Aurore Garde, Ange-Line Bruel, Frederic Tran Mau-Them, Alexis B. R. Maddocks, Jennifer M. Bain, Musadiq A. Bhat, Gregory Costain, Peter Kannu, Ashish Marwaha, Neena L. Champaigne, Michael J. Friez, Ellen B. Richardson, Vykuntaraju K. Gowda, Varunvenkat M. Srinivasan, Yask Gupta, Tze Y. Lim, Simone Sanna-Cherchi, Bruno Lemaitre, Toshiyuki Yamaji, Kentaro Hanada, John E. Burke, Ana Marjia Jaksic, Brian D. McCabe, Paolo De Los Rios, Thorsten Hornemann, Giovanni D'Angelo, Vincenzo A. Gennarino

Summary: By studying individuals with de novo missense variants in CERT1, it was found that CERT autoregulation plays a central role in the control of sphingolipid biosynthetic flux. Inhibiting CERT pharmacologically can correct the morphological and motor abnormalities in CerTra syndrome, suggesting a potential therapeutic approach for patients.

JOURNAL OF CLINICAL INVESTIGATION (2023)

暂无数据